首页> 外文期刊>Acta Societatis Botanicorum Poloniae >Analysis and glycosyl composition of the exopolysaccharide isolated from submerged fermentation of Ganoderma lucidum CG144
【24h】

Analysis and glycosyl composition of the exopolysaccharide isolated from submerged fermentation of Ganoderma lucidum CG144

机译:灵芝CG144深层发酵分离的胞外多糖的分析及糖基组成

获取原文
           

摘要

The evaluation of glycosyl composition is an essential step to guide future research designs applied in bioactivity. In the same way, the unexplored potential bioactivity of exopolysaccharide from Ganoderma lucidum is huge. Therefore, this study investigated the glycosyl composition of the exopolysaccharide isolated from submerged fermentation of G. lucidum to serve as guide for future studies on bioactivity. Glycosyl content and composition were evaluated by combined GC/MS of the TMS derivatives of the monosaccharide methyl glycosides produced from the sample by acidic methanolysis. Glycosyl composition analysis showed that the dominant carbohydrate component in all samples of exopolysaccharide isolated from submerged fermentation of G. lucidum CG 144 was glucose (58.1%), mannose (26.6%) and galactose (12.5%) which can be referred to as heteroglycan. These results suggest that this Ganoderma exopolysaccharide may be a new immunomodulatory agent.
机译:糖基组成的评估是指导未来应用于生物活性研究设计的重要步骤。同样,来自灵芝的胞外多糖的未开发的潜在生物活性是巨大的。因此,本研究调查了从灵芝的深层发酵中分离出的胞外多糖的糖基组成,以作为未来生物活性研究的指南。糖基含量和组成通过结合GC / MS评估了通过酸性甲醇分解从样品中产生的单糖甲基糖苷的TMS衍生物。糖基组成分析表明,从透明链CG 144的深层发酵中分离出的所有胞外多糖样品中的主要碳水化合物成分为葡萄糖(58.1%),甘露糖(26.6%)和半乳糖(12.5%),可称为杂聚糖。这些结果表明该灵芝胞外多糖可能是一种新的免疫调节剂。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号